Artificial intelligence and machine learning for magnetic nanoparticles and nanocarriers in cancer imaging, drug delivery, and magnetic control: a systematic review
- 1Academy of Life and Natural Sciences, Xi’an Jiaotong Liverpool University, 215123, Suzhou, China
Abstract
We reviewed artificial intelligence and machine learning in magnetic resonance imaging-visible magnetic nanoparticles, nanocarriers, and systems for imaging, drug delivery, hyperthermia, targeting, transport, and control. Using “preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020” methods, 2,283 records from seven databases yielded 65 studies. Predicted outcomes were colloidal stability, toxicity, uptake, magnetic descriptors, specific absorption rate, relaxivity, MRI signal, superparamagnetic iron oxide nanoparticle (SPION) quantification, drug release, biodistribution, and magnetic navigation. Evidence was strongest in bounded tasks: magnetic-property and relaxivity prediction, image-derived SPION mapping, hyperthermia modelling, and controlled magnetic transport. Most studies optimised isolated endpoints rather than integrating stability, MRI visibility, drug loading, release, tumour delivery, safety, and therapeutic response. External validation across datasets, laboratories, particle batches, biological models, scanners, and patient cohorts remains limited.
Related
- Advancing Nuclear Physics with Machine Learning and Artificial Intelligence
- Artificial intelligence in image-guided cervical interventional radiotherapy: a systematic review
- Transfer learning-aided, artificial intelligence approach to evaluate optical properties of materials for classical and quantum photonic applications
- Deep learning-based self-supervised detection and localization of magnetic resonance imaging anomalies in artificial intelligence-supported radiotherapy workflows
- Using artificial intelligence for clinical trial quality assurance in a multi-institutional neurovascular-sparing prostate radiotherapy trial
BibTeX
@article{yao2026artificial,
title = {{Artificial intelligence and machine learning for magnetic nanoparticles and nanocarriers in cancer imaging, drug delivery, and magnetic control: a systematic review}},
author = {Yier Yao and Wanis Nafo},
journal = {Beilstein Journal of Nanotechnology},
year = {2026},
month = oct,
doi = {10.3762/bjnano.17.98},
url = {https://doi.org/10.3762/bjnano.17.98},
note = {CC BY},
}
RIS
TY - JOUR
TI - Artificial intelligence and machine learning for magnetic nanoparticles and nanocarriers in cancer imaging, drug delivery, and magnetic control: a systematic review
AU - Yier Yao
AU - Wanis Nafo
PY - 2026
DA - 2026/10/01
JO - Beilstein Journal of Nanotechnology
DO - 10.3762/bjnano.17.98
UR - https://doi.org/10.3762/bjnano.17.98
AB - We reviewed artificial intelligence and machine learning in magnetic resonance imaging-visible magnetic nanoparticles, nanocarriers, and systems for imaging, drug delivery, hyperthermia, targeting, transport, and control. Using “preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020” methods, 2,283 records from seven databases yielded 65 studies. Predicted outcomes were colloidal stability, toxicity, uptake, magnetic descriptors, specific absorption rate, relaxivity, MRI signal, superparamagnetic iron oxide nanoparticle (SPION) quantification, drug release, biodistribution, and magnetic navigation. Evidence was strongest in bounded tasks: magnetic-property and relaxivity prediction, image-derived SPION mapping, hyperthermia modelling, and controlled magnetic transport. Most studies optimised isolated endpoints rather than integrating stability, MRI visibility, drug loading, release, tumour delivery, safety, and therapeutic response. External validation across datasets, laboratories, particle batches, biological models, scanners, and patient cohorts remains limited.
SN - 2190-4286
ER -